
Your Feed
Belantamab Mafodotin in Myeloma: Can a Questionnaire Replace Eye Exams? | IMS 2026
Does Intensive Treatment Affect Quality of Life in High-Risk Myeloma? | RADAR Trial | IMS 2026
Colon cancer in young adults: symptoms, risk factors and screening

AL Amyloidosis Bispecific Trial: Who Qualifies, Response , Side Effects & Organ Response | IMS 2026
Can Multiple Myeloma Be Cured? MRD Negativity, Stopping Treatment & Confirming Cure | IMS 2026
What a 3-Month PET-CT Can Predict About CAR-T Outcomes in Multiple Myeloma | IMS 2026
Rethinking Early Myeloma Care: Is Transplant Still Necessary? | Jorge Monge, MD
In Vivo CAR-T for Multiple Myeloma: Could It Improve Access and Skip Chemotherapy? | IMS 2026
Etentamig for Relapsed Multiple Myeloma: New Bispecific Shows Strong Results, Low CRS | IMS 2026
Multiple Myeloma Treatment for Older Adults: Who Should Get Quadruplet Therapy? | IMS 2026
What is Ecotherapy? How Nature Therapy Can Help People With Cancer












